HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoyuki Tamaki Selected Research

Motoyuki Tamaki Research Topics

Disease

8Type 2 Diabetes Mellitus (MODY)
10/2018 - 08/2008
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2022 - 03/2017
2Diabetic Angiopathies (Diabetic Angiopathy)
09/2019 - 01/2015
2Atherosclerosis
01/2015 - 01/2011
2Insulin Resistance
01/2014 - 06/2011
1Sarcopenia
09/2019
1Body Weight (Weight, Body)
10/2018
1Muscle Weakness
05/2017
1Carotid Artery Diseases
01/2015
1Amyloid Plaque
08/2014
1Diabetes Mellitus
06/2011
1Critical Illness (Critically Ill)
09/2008

Drug/Important Bio-Agent (IBA)

8Insulin (Novolin)FDA Link
07/2022 - 08/2008
3Advanced Glycation End ProductsIBA
09/2019 - 01/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
10/2018 - 11/2013
2Dipeptidyl-Peptidase IV InhibitorsIBA
10/2018 - 11/2013
2Insulin Glargine (Lantus)FDA Link
03/2017 - 08/2008
1DNA (Deoxyribonucleic Acid)IBA
07/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2018
1LiraglutideFDA Link
10/2018
1insulin degludecIBA
03/2017
1Glucose (Dextrose)FDA LinkGeneric
03/2017
1Biomarkers (Surrogate Marker)IBA
01/2015
1Islet Amyloid PolypeptideIBA
08/2014
1ZincIBA
01/2014
1Glycoside Hydrolase InhibitorsIBA
11/2013
1Pharmaceutical PreparationsIBA
06/2011
1Pioglitazone (Actos)FDA Link
01/2011

Therapy/Procedure

4Therapeutics
10/2018 - 08/2008
3Glycemic Control
11/2013 - 08/2008
1Injections
03/2017